Related Experiment Video

Updated: Jul 15, 2026

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
13:09

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol

Published on: April 1, 2018

Place of electroencephalograpic biofeedback for attention-deficit/hyperactivity disorder

Laurence M Hirshberg

    Expert Review of Neurotherapeutics
    |April 12, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
    10:02

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

    Published on: March 12, 2020

    A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
    07:05

    A Protocol for the Administration of Real-Time fMRI Neurofeedback Training

    Published on: August 24, 2017

    Related Experiment Videos

    Last Updated: Jul 15, 2026

    Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
    13:09

    Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol

    Published on: April 1, 2018

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
    10:02

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

    Published on: March 12, 2020

    A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
    07:05

    A Protocol for the Administration of Real-Time fMRI Neurofeedback Training

    Published on: August 24, 2017

    Related Concept Videos

    Attention-Deficit/Hyperactivity Disorder01:30

    Attention-Deficit/Hyperactivity Disorder

    Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
    Diagnostic Criteria and Symptoms
    To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

    Articles linked to this work by shared authors, journal, and citation graph.

    Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist).

    Brain : a journal of neurology·2020

    Emerging brain-based interventions for children and adolescents: overview and clinical perspective.

    Child and adolescent psychiatric clinics of North America·2004

    A status update on the unkept promise of high-frequency spinal cord stimulation for treatment-refractory chronic migraine.

    Expert review of neurotherapeutics·2026

    Profiling intranasal esketamine for adults with major depressive disorder and acute suicidal ideation or behavior: a phenotype-informed drug profile.

    Expert review of neurotherapeutics·2026

    Sleep and circadian disruption as transdiagnostic drivers of psychosis: a unified mechanistic framework.

    Expert review of neurotherapeutics·2026

    An overview of current and emerging strategies for phantom limb pain.

    Expert review of neurotherapeutics·2026

    Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?

    Expert review of neurotherapeutics·2026

    Can the integration of blood-based biomarkers into Alzheimer's disease diagnosis revolutionize the field?

    Expert review of neurotherapeutics·2026

    Effectiveness of a digital cognitive behavioral therapy application for vasomotor symptoms in menopausal women: An open-label pilot randomized controlled trial.

    Maturitas·2026

    A biphasic hydrogel prevents glioblastoma recurrence by activating an EZH2-NeuroD1-SRCIN1 neuronal conversion axis.

    Biomaterials·2026

    A Three-Point, Low-Dose, Artery-Targeted Botulinum Toxin Treatment for Chronic Migraine: A Randomized, Double-Blind, Contralateral-Controlled Trial.

    Aesthetic plastic surgery·2026

    3D-printed biomimetic scaffolds integrated with exosomes from injury-preconditioned hUCMSCs promote brain tissue repair via neuroprotection and neurogenesis.

    Journal of materials chemistry. B·2026

    The Bacterial Metabolite Lndole-3-Propionic Acid Alleviates Acetaminophen-Induced Acute Liver Injury Partly through the Aryl Hydrocarbon Receptor Pathway.

    Journal of microbiology and biotechnology·2026

    Merging artificial intelligence and retinal vascular geometric parameters: A novel tool for diagnosis and prognosis prediction of diabetic nephropathy.

    Chinese medical journal·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us